Results 241 to 250 of about 1,571,650 (304)
Pathologica, 1977 Some of the next articles are maybe not open access.
Related searches:
Related searches:
Myocardial infarction and oral contraceptive agents
American Journal of Cardiology, 1971Abstract Three young premenopausal women, aged 27, 29 and 35 years, with acute myocardial infarction in the absence of significant predisposing causes are presented. All 3 patients were taking oral contraceptive agents at the time of infarction. Selective coronary arteriograms showed an isolated segmental occlusion in all cases with no other arterial
William Likoff +2 more
exaly +3 more sources
Noncontraceptive Use of Contraceptive Agents
Pediatrics In Review, 2014• On the basis of strong research evidence, there are many noncontraceptive advantages to use of hormonal contraceptive agents in adolescent girls. (3) (4)(5)(7)(10)(11)(12)(13)(14). • On the basis of research evidence and consensus, most of these agents are safe with minor adverse effects. (2)(3)(4)(5)(7)(10)(11)(12)(13)(14).
Monique Collier, Nickles +1 more
openaire +2 more sources
Investigation of Danazol as a contraceptive agent
Contraception, 1976Abstract Danazol, the 2,3-isoxasol derivative of 17 α -ethinyl testosterone, was administered to 17 healthy volunteers during the first 7 days of the menstrual cycle, to see if an inadequate luteal phase would result. The follicular span was lengthened, and FSH levels either did not increase or were lowered during Danazol dosage in most women ...
A C, Wentz, G S, Jones, K C, Sapp
openaire +2 more sources
The Pharmacology of Contraceptive Agents
Annual Review of Pharmacology, 1974Some aspects of the pharmacology and physiology of contraceptive agents administered to women are reviewed. Hormonal events during the normal menstrual cycle are described. Contraceptive compounds in addition to modifying the hormonal control of ovarian function also may act on later stages of fertility (i.e.
W. D. Odell, M. E. Molitch
openaire +1 more source
Medical Journal of Australia, 1986
PIP: The history of the development of oral contraceptives (OCs) has been a progressive reduction in dosage to what is now probably the lowest does that is compatible with the desired therapeutic effect -- to inhibit ovluation. Yet, controversy and argument continue. A table lists the OCs that are available in Australia.
openaire +2 more sources
PIP: The history of the development of oral contraceptives (OCs) has been a progressive reduction in dosage to what is now probably the lowest does that is compatible with the desired therapeutic effect -- to inhibit ovluation. Yet, controversy and argument continue. A table lists the OCs that are available in Australia.
openaire +2 more sources
American Journal of Obstetrics and Gynecology, 2011
Currently available contraceptive methods have not eliminated the burden of unintended pregnancy. Future progress will require technological advancements, leading to the development of novel and highly effective birth control strategies that will be acceptable to the general population.
openaire +2 more sources
Currently available contraceptive methods have not eliminated the burden of unintended pregnancy. Future progress will require technological advancements, leading to the development of novel and highly effective birth control strategies that will be acceptable to the general population.
openaire +2 more sources
Effect of contraceptive agents on drug metabolism
European Journal of Pharmacology, 1969Abstract A series of steroids including progesterone, medroxyprogesterone, norethynodrel, estrone, mestranol and ethynylestradiol have been administered either acutely of chronically, alone or in combination, to rats to test for possible effects on drug metabolism.
A, Jori, A, Bianchetti, P E, Prestini
openaire +2 more sources
Quinestrol: A Potential Contraceptive Agent
Fertility and Sterility, 1969To test the contraceptive effectiveness of the estrogen derivative Quinestrol 6 women 23-30 years old with confirmed fertility were administered 1 mg Quinestrol orally on Days 1 8 and 15 of the cycle for a total of 34 treated cycles. A single oral dose of 20 mg medroxyprogesterone acetate was administered on Day 22 to achieve proper cyclic withdrawal ...
openaire +2 more sources